Table 2

Demographic and clinical characteristics of the independent dataset.

CharacteristicsPDHCStatisticsP-value
Number of subjects4628
Sex (M/F)24/2215/13X2 = 0.0140.907
Age (years)64.18 ± 9.3864.18 ± 8.14t = 0.0020.998
Education (years)10.23 ± 2.889.81 ± 3.39t = 0.5690.571
Disease duration (years)4.31 ± 3.05NA
H&Y2.09 ± 0.78NA
UPDRS-III scores23.77 ± 12.06NA
CharacteristicsPDHCStatisticsP-value
Number of subjects4628
Sex (M/F)24/2215/13X2 = 0.0140.907
Age (years)64.18 ± 9.3864.18 ± 8.14t = 0.0020.998
Education (years)10.23 ± 2.889.81 ± 3.39t = 0.5690.571
Disease duration (years)4.31 ± 3.05NA
H&Y2.09 ± 0.78NA
UPDRS-III scores23.77 ± 12.06NA

Abbreviations: HC, healthy controls; H&Y, Hoehn & Yahr scales; NA, not applicable; PD, patients with Parkinson’s disease; UPDRS-III, Unified Parkinson’s Disease Rating Scale.

Table 2

Demographic and clinical characteristics of the independent dataset.

CharacteristicsPDHCStatisticsP-value
Number of subjects4628
Sex (M/F)24/2215/13X2 = 0.0140.907
Age (years)64.18 ± 9.3864.18 ± 8.14t = 0.0020.998
Education (years)10.23 ± 2.889.81 ± 3.39t = 0.5690.571
Disease duration (years)4.31 ± 3.05NA
H&Y2.09 ± 0.78NA
UPDRS-III scores23.77 ± 12.06NA
CharacteristicsPDHCStatisticsP-value
Number of subjects4628
Sex (M/F)24/2215/13X2 = 0.0140.907
Age (years)64.18 ± 9.3864.18 ± 8.14t = 0.0020.998
Education (years)10.23 ± 2.889.81 ± 3.39t = 0.5690.571
Disease duration (years)4.31 ± 3.05NA
H&Y2.09 ± 0.78NA
UPDRS-III scores23.77 ± 12.06NA

Abbreviations: HC, healthy controls; H&Y, Hoehn & Yahr scales; NA, not applicable; PD, patients with Parkinson’s disease; UPDRS-III, Unified Parkinson’s Disease Rating Scale.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close